Mod­er­na taps in­to Aus­tralia with Covid-19 boost­er deal and the po­ten­tial for lo­cal man­u­fac­tur­ing

Ear­li­er this month, Mod­er­na an­nounced pos­i­tive da­ta from its Phase II study of a boost­er shot of its Covid-19 vac­cine, de­signed to pro­tect against the vari­ants of the virus that have. rocked South Africa, Brazil and oth­er parts of the world. Now, the com­pa­ny has struck a deal for mil­lions of dos­es of that jab with Aus­tralia, and it is ex­plor­ing lo­cal man­u­fac­tur­ing op­por­tu­ni­ties on the con­ti­nent as well.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.